Variant report

Variant	esv3520544
Chromosome Location	chr12:291541-297739
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr12:294691-295034	K562	blood:	n/a	chr12:294869-294878 chr12:294870-294879 chr12:294867-294880 chr12:294868-294877 chr12:294869-294878
2	BHLHE40	chr12:294714-295081	HepG2	liver:	n/a	chr12:294869-294878 chr12:294870-294879 chr12:294867-294880 chr12:294868-294877 chr12:294869-294878
3	CHD2	chr12:291781-291791	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr12:291500-291650	GM12878	blood:	n/a	n/a
5	CTCF	chr12:296060-296210	A549	lung:	n/a	chr12:296091-296112 chr12:296096-296114 chr12:296098-296111
6	CTCF	chr12:296080-296230	HepG2	liver:	n/a	chr12:296091-296112 chr12:296096-296114 chr12:296098-296111
7	CTCF	chr12:295740-295890	WERI-Rb-1	eye:	n/a	n/a
8	CTCF	chr12:296040-296330	GM12865	blood:	n/a	chr12:296091-296112 chr12:296096-296114 chr12:296098-296111
9	CTCF	chr12:295997-296216	HepG2	liver:	n/a	chr12:296091-296112 chr12:296096-296114 chr12:296098-296111
10	CTCF	chr12:296689-296843	K562	blood:	n/a	n/a
11	CTCF	chr12:296680-296830	HepG2	liver:	n/a	n/a
12	CTCF	chr12:296082-296194	HepG2	liver:	n/a	chr12:296091-296112 chr12:296096-296114 chr12:296098-296111
13	CTCF	chr12:296125-296153	H1-hESC	embryonic stem cell:	n/a	n/a
14	E2F4	chr12:291874-292070	MCF10A-Er-Src	breast:	n/a	n/a
15	EP300	chr12:291348-292077	ECC-1	luminal epithelium:	n/a	chr12:291400-291416
16	EP300	chr12:291474-292036	ECC-1	luminal epithelium:	n/a	n/a
17	ESR1	chr12:294849-295101	ECC-1	luminal epithelium:	n/a	n/a
18	ESR1	chr12:294839-295037	ECC-1	luminal epithelium:	n/a	n/a
19	ESR1	chr12:291430-291973	ECC-1	luminal epithelium:	n/a	chr12:291750-291765
20	ESR1	chr12:294662-295210	ECC-1	luminal epithelium:	n/a	n/a
21	ESR1	chr12:294762-295125	ECC-1	luminal epithelium:	n/a	n/a
22	ESR1	chr12:291634-291905	ECC-1	luminal epithelium:	n/a	chr12:291750-291765
23	ESR1	chr12:291411-291990	ECC-1	luminal epithelium:	n/a	chr12:291750-291765
24	ESR1	chr12:291517-291957	ECC-1	luminal epithelium:	n/a	chr12:291750-291765
25	FOS	chr12:291814-292174	MCF10A-Er-Src	breast:	n/a	chr12:291990-292001 chr12:291990-292002 chr12:291992-292000
26	FOS	chr12:291814-292169	MCF10A-Er-Src	breast:	n/a	chr12:291990-292001 chr12:291990-292002 chr12:291992-292000
27	FOS	chr12:291833-292174	HUVEC	blood vessel:	n/a	chr12:291990-292001 chr12:291990-292002 chr12:291992-292000
28	FOS	chr12:291806-292183	MCF10A-Er-Src	breast:	n/a	chr12:291990-292001 chr12:291990-292002 chr12:291992-292000
29	FOS	chr12:291818-292171	MCF10A-Er-Src	breast:	n/a	chr12:291990-292001 chr12:291990-292002 chr12:291992-292000
30	FOSL1	chr12:291666-292340	HCT-116	colon:	n/a	chr12:291990-292002 chr12:291992-292000
31	FOSL1	chr12:291715-292258	HCT-116	colon:	n/a	chr12:291990-292002 chr12:291992-292000
32	FOSL1	chr12:291832-292071	K562	blood:	n/a	chr12:291990-292002 chr12:291992-292000
33	FOSL2	chr12:291679-292220	A549	lung:	n/a	chr12:291990-292002 chr12:291992-292000
34	FOSL2	chr12:291813-292055	A549	lung:	n/a	chr12:291990-292002 chr12:291992-292000
35	FOSL2	chr12:291657-292303	SK-N-SH	brain:	n/a	chr12:291990-292002 chr12:291992-292000
36	FOSL2	chr12:291749-292106	SK-N-SH	brain:	n/a	chr12:291990-292002 chr12:291992-292000
37	FOXA2	chr12:296679-297148	A549	lung:	n/a	n/a
38	FOXA2	chr12:296592-297013	A549	lung:	n/a	n/a
39	HEY1	chr12:296686-296895	HepG2	liver:	n/a	n/a
40	JUND	chr12:291702-292323	SK-N-SH	brain:	n/a	chr12:291990-292002 chr12:291992-292000
41	JUND	chr12:291674-292326	SK-N-SH	brain:	n/a	chr12:291990-292002 chr12:291992-292000
42	MAX	chr12:291845-292117	NB4	blood:	n/a	n/a
43	MAX	chr12:297680-298674	H1-hESC	embryonic stem cell:	n/a	n/a
44	MAZ	chr12:291188-292528	IMR90	lung:	n/a	n/a
45	MYC	chr12:295166-295312	H1-hESC	embryonic stem cell:	n/a	n/a
46	MYC	chr12:291790-292078	NB4	blood:	n/a	n/a
47	NFYA	chr12:296739-297006	K562	blood:	n/a	n/a
48	NFYB	chr12:296626-297032	GM12878	blood:	n/a	n/a
49	NFYB	chr12:296658-297162	K562	blood:	n/a	n/a
50	NFYB	chr12:296759-297023	Hela-S3	cervix:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:296473-296523	HEK293	kidney:	embryo
2	chr12:296540-296590	HMEC	breast:	n/a
3	chr12:296473-296523	HEK293	kidney:	embryo
4	chr12:296540-296590	HMEC	breast:	n/a
5	chr12:297356-297406	SAEC	small airway:	n/a
6	chr12:291668-291718	HRCEpiC	kidney:	n/a
7	chr12:297356-297406	HRE	kidney:	n/a
8	chr12:297356-297406	MCF-7	breast:	n/a
9	chr12:291668-291718	AG09309	skin:	n/a
10	chr12:296609-296659	HRPEpiC	eye:	n/a
11	chr12:297356-297406	SKMC	muscle:	n/a
12	chr12:296540-296590	IMR90	lung:	fetal
13	chr12:295951-296001	AoSMC	blood vessel:	n/a
14	chr12:296540-296590	CMK	blood:	n/a
15	chr12:295951-296001	BJ	skin:	n/a
16	chr12:296473-296523	HNPCEpiC	eye:	n/a
17	chr12:295951-296001	SK-N-MC	brain:	n/a
18	chr12:295951-296001	NT2-D1	testis:	n/a
19	chr12:291668-291718	HAEpiC	amniotic membrane:	n/a
20	chr12:297356-297406	SK-N-MC	brain:	n/a
21	chr12:297356-297406	U87	brain:	n/a
22	chr12:296540-296590	A549	lung:	n/a
23	chr12:291668-291718	T-47D	breast:	n/a
24	chr12:296540-296590	SK-N-SH	brain:	n/a
25	chr12:296609-296659	ovcar-3	ovarian:	n/a
26	chr12:295951-296001	PANC-1	pancreas:	n/a
27	chr12:296540-296590	Hela-S3	cervix:	n/a
28	chr12:296473-296523	GM19239	blood:	n/a
29	chr12:297356-297406	HUVEC	blood vessel:	n/a
30	chr12:291668-291718	HRPEpiC	eye:	n/a
31	chr12:297356-297406	H1-hESC	embryonic stem cell:	embryo
32	chr12:291668-291718	HCM	heart:	n/a
33	chr12:291668-291718	CMK	blood:	n/a
34	chr12:297356-297406	AG10803	skin:	n/a
35	chr12:296609-296659	NHDF-neo	bronchial:	n/a
36	chr12:297356-297406	PANC-1	pancreas:	n/a
37	chr12:291668-291718	GM19239	blood:	n/a
38	chr12:296609-296659	Hepatocyte	liver:	n/a
39	chr12:296609-296659	U87	brain:	n/a
40	chr12:296609-296659	HMEC	breast:	n/a
41	chr12:291668-291718	AG04449	skin:	fetal
42	chr12:291668-291718	BJ	skin:	n/a
43	chr12:297356-297406	ovcar-3	ovarian:	n/a
44	chr12:295951-296001	A549	lung:	n/a
45	chr12:291668-291718	ovcar-3	ovarian:	n/a
46	chr12:297356-297406	GM06990	blood:	n/a
47	chr12:291668-291718	ProgFib	skin:	n/a
48	chr12:296473-296523	HL-60	blood:	n/a
49	chr12:296609-296659	A549	lung:	n/a
50	chr12:296609-296659	NHBE	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:211691..214245-chr12:294558..297175,2	K562	blood:
2	chr12:297600..300406-chr12:301639..304265,3	K562	blood:
3	chr12:296668..298848-chr12:310032..311975,2	K562	blood:
4	chr12:297600..300406-chr12:301338..304265,4	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SLC6A12-1	chr12:291234-291565	ENSG00000256540
2	lnc-SLC6A12-1	chr12:291234-291562	ENSG00000256540

Variant related genes	Relation type
ENSG00000256540	TF binding region
ENSG00000255671	TF binding region
ENSG00000256540	CpG island
ENSG00000255671	CpG island
ENSG00000255671	chromatin interactions
ENSG00000111181	chromatin interactions

Extended variants
information (count: 470 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:470 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs542865578	chr12:291617-291618	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs529466927	chr12:291668-291669	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs200850407	chr12:291712-291713	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
4	rs543993002	chr12:291715-291716	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs397825804	chr12:291716-291717	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
6	rs562532778	chr12:291738-291739	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs532966467	chr12:291739-291740	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs567875701	chr12:291780-291781	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs149625104	chr12:291809-291810	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs562715430	chr12:291819-291820	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs527623488	chr12:291822-291823	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs549245749	chr12:291832-291833	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs567378500	chr12:291842-291843	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs188910973	chr12:291905-291906	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs61144307	chr12:291910-291911	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs58487822	chr12:291934-291935	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs539454239	chr12:291986-291987	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs76453552	chr12:292046-292047	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs546022730	chr12:292052-292053	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs564418718	chr12:292090-292091	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs144316384	chr12:292106-292107	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs578261925	chr12:292128-292129	Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs574871903	chr12:292211-292212	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs531906582	chr12:292212-292213	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs555995181	chr12:292224-292225	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs574165204	chr12:292237-292238	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs547748907	chr12:292255-292256	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs193243438	chr12:292262-292263	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs544748366	chr12:292287-292288	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs535911066	chr12:292322-292323	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs76758333	chr12:292324-292325	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs557335506	chr12:292357-292358	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs370850792	chr12:292433-292434	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs575506340	chr12:292491-292492	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs553705938	chr12:292514-292515	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs560224026	chr12:292534-292535	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs543380927	chr12:292547-292548	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs185350467	chr12:292548-292549	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs572977478	chr12:292558-292559	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs540082771	chr12:292595-292596	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs564725709	chr12:292628-292629	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs148749699	chr12:292634-292635	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs572227028	chr12:292671-292672	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs7967649	chr12:292716-292717	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs556595861	chr12:292727-292728	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs148117887	chr12:292728-292729	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs114874412	chr12:292733-292734	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs368543258	chr12:292738-292739	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs7976156	chr12:292755-292756	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs562525134	chr12:292766-292767	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:152 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:277200-292800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr12:284200-292000	Enhancers	Right Atrium	heart
3	chr12:284200-292600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr12:285400-292200	Enhancers	Primary hematopoietic stem cells short term culture	blood
5	chr12:286200-295800	Weak transcription	Liver	Liver
6	chr12:286200-298000	Weak transcription	Gastric	stomach
7	chr12:286800-291600	Weak transcription	Placenta Amnion	Placenta Amnion
8	chr12:288200-291800	Enhancers	Fetal Muscle Leg	muscle
9	chr12:288200-292400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr12:288200-292800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
11	chr12:288400-291800	Enhancers	Primary hematopoietic stem cells	blood
12	chr12:288400-295200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr12:288400-297800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr12:288600-291600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr12:288800-297200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr12:289200-291600	Weak transcription	A549	lung
17	chr12:289200-297800	Weak transcription	Brain Anterior Caudate	brain
18	chr12:289600-298200	Weak transcription	HSMMtube	muscle
19	chr12:290000-292000	Weak transcription	Fetal Kidney	kidney
20	chr12:290000-297800	Weak transcription	Brain Inferior Temporal Lobe	brain
21	chr12:290000-297800	Weak transcription	HUVEC	blood vessel
22	chr12:290000-298000	Weak transcription	Esophagus	oesophagus
23	chr12:290200-291600	Weak transcription	Monocytes-CD14+_RO01746	blood
24	chr12:290200-297800	Weak transcription	Brain Hippocampus Middle	brain
25	chr12:290600-291600	Weak transcription	Primary monocytes fromperipheralblood	blood
26	chr12:290800-292000	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr12:291000-292000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr12:291000-292000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
29	chr12:291000-292000	Enhancers	Skeletal Muscle Female	skeletal muscle
30	chr12:291000-292400	Enhancers	NHLF	lung
31	chr12:291000-292600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr12:291000-292600	Enhancers	NH-A	brain
33	chr12:291000-292600	Enhancers	NHDF-Ad	bronchial
34	chr12:291200-291600	Flanking Active TSS	Right Ventricle	heart
35	chr12:291200-291600	ZNF genes & repeats	Spleen	Spleen
36	chr12:291200-291800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
37	chr12:291200-292000	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr12:291200-292000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr12:291200-292000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr12:291200-292000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
41	chr12:291200-292000	Enhancers	Stomach Mucosa	stomach
42	chr12:291200-292200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr12:291200-292200	Enhancers	HSMM	muscle
44	chr12:291200-292400	Enhancers	Osteobl	bone
45	chr12:291200-297600	Weak transcription	Pancreas	Pancrea
46	chr12:291400-291600	Enhancers	H1 Cell Line	embryonic stem cell
47	chr12:291400-291600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr12:291400-291600	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
49	chr12:291400-291600	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
50	chr12:291400-292000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links